Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2
Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy
- Status
- COMPLETED
- Phase
- NA
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
- Status
- TERMINATED
- Phase
- PHASE2
A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of Pembrolizumab In Combination With Trastuzumab-DM1
- Status
- COMPLETED
- Phase
- PHASE1
The HOPE Trial and the SMART Study
- Status
- COMPLETED
- Phase
- NA
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
CISPLATIN + AZD-1775 In Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Abemaciclib in Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
- Status
- TERMINATED
- Phase
- PHASE2
Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket
- Status
- COMPLETED
- Phase
- NA
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2